We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$400B
AUM Growth
-$75.9B
Cap. Flow
+$5.41B
Cap. Flow %
1.35%
Top 10 Hldgs %
18.01%
Holding
6,980
New
409
Increased
2,565
Reduced
2,533
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Healthcare 9.3%
3 Financials 8.52%
4 Consumer Discretionary 7.65%
5 Industrials 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RJAC.WS
5951
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$35K ﹤0.01%
230,182
MFGP
5952
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$35K ﹤0.01%
10,378
-50,653
-83% -$235K
SMMT icon
5953
Summit Therapeutics
SMMT
$10.4B
$34K ﹤0.01%
34,393
-2,384
-6% -$3.34K
ACHL
5954
DELISTED
Achilles Therapeutics
ACHL
$34K ﹤0.01%
13,329
-920
-6% -$2.27K
MTVC.WS
5955
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$34K ﹤0.01%
130,989
AVACW
5956
DELISTED
Avalon Acquisition Inc. Warrant
AVACW
$34K ﹤0.01%
379,725
ADALW
5957
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$34K ﹤0.01%
258,909
CADL icon
5958
Candel Therapeutics
CADL
$733M
$33K ﹤0.01%
10,037
-473
-5% -$1.89K
DRTSW icon
5959
Alpha Tau Medical Warrant
DRTSW
$63M
$33K ﹤0.01%
69,409
LGACW
5960
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$33K ﹤0.01%
136,669
GROY icon
5961
Gold Royalty Corp
GROY
$600M
$32K ﹤0.01%
14,014
GTBP icon
5962
GT Biopharma
GTBP
$10.6M
$32K ﹤0.01%
355
-1
-0.3% -$76
MSAIW icon
5963
MultiSensor AI Holdings Warrant
MSAIW
$32K ﹤0.01%
201,371
RDHL
5964
Redhill Biopharma
RDHL
$3.95M
$32K ﹤0.01%
36
-1
-3% -$1.37K
PNST.WS
5965
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$32K ﹤0.01%
249,850
NHICW
5966
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$32K ﹤0.01%
162,356
VLTA
5967
PUT
DELISTED
Volta Inc.
VLTA
$32K ﹤0.01%
25,000
QFTA.WS
5968
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$32K ﹤0.01%
457,573
CLSD
5969
DELISTED
Clearside Biomedical
CLSD
$31K ﹤0.01%
1,408
-1,015
-42% -$24.6K
HYMC icon
5970
Hycroft Mining Holding Corp
HYMC
$1.82B
$31K ﹤0.01%
+2,753
New +$40.8K
PYXS icon
5971
Pyxis Oncology
PYXS
$168M
$31K ﹤0.01%
+12,882
New +$34.3K
PGSS.WS
5972
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$31K ﹤0.01%
75,239
TRCA.WS
5973
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$31K ﹤0.01%
309,716
LABP
5974
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$31K ﹤0.01%
4,280
+2,326
+119% +$21.2K
GNPX icon
5975
Genprex
GNPX
$3.02M
-3
Closed -$211K

Similar funds

Goldman Sachs's Q2 2022 Portfolio in Review

As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q2 2022 filing shows 409 new, 2,565 increased, 2,533 reduced and 543 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
  • Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
  • Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
  • Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
  • Goldman Sachs opened 409 new positions and closed 543 in Q2 2022.
  • Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.